These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes. Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844 [TBL] [Abstract][Full Text] [Related]
5. Recent advances in nanoparticle applications in respiratory disorders: a review. Taghavizadeh Yazdi ME; Qayoomian M; Beigoli S; Boskabady MH Front Pharmacol; 2023; 14():1059343. PubMed ID: 37538179 [TBL] [Abstract][Full Text] [Related]
6. Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. Anderson CF; Grimmett ME; Domalewski CJ; Cui H Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1586. PubMed ID: 31602823 [TBL] [Abstract][Full Text] [Related]
7. Nanosize drug delivery system. Mukherjee B Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648 [TBL] [Abstract][Full Text] [Related]
8. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives. Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609 [TBL] [Abstract][Full Text] [Related]
9. Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases. Passi M; Shahid S; Chockalingam S; Sundar IK; Packirisamy G Int J Nanomedicine; 2020; 15():3803-3826. PubMed ID: 32547029 [TBL] [Abstract][Full Text] [Related]
10. Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD). Nagar L; Gulati N; Saini A; Singh S; Gupta G; MacLoughlin R; Chellappan DK; Dua K; Dureja H Curr Drug Deliv; 2024 Mar; ():. PubMed ID: 38445696 [TBL] [Abstract][Full Text] [Related]
11. Opportunities and Challenges for Inhalable Nanomedicine Formulations in Respiratory Diseases: A Review. Feng X; Shi Y; Zhang Y; Lei F; Ren R; Tang X Int J Nanomedicine; 2024; 19():1509-1538. PubMed ID: 38384321 [TBL] [Abstract][Full Text] [Related]
13. [Inhalative pharmacotherapy in the future--nanocarriers for pulmonary drug delivery]. Gessler T Pneumologie; 2009 Dec; 63 Suppl 2():S113-6. PubMed ID: 20013540 [TBL] [Abstract][Full Text] [Related]
14. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world. Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315 [TBL] [Abstract][Full Text] [Related]
15. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement. Pandey J; Dubey R; Kate A; Prasad B; Sinha A; Mishra MS Drug Res (Stuttg); 2022 Sep; 72(7):355-366. PubMed ID: 35636435 [TBL] [Abstract][Full Text] [Related]
16. Recent applications and strategies in nanotechnology for lung diseases. Zhong W; Zhang X; Zeng Y; Lin D; Wu J Nano Res; 2021; 14(7):2067-2089. PubMed ID: 33456721 [TBL] [Abstract][Full Text] [Related]
17. Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance. Rhaman MM; Islam MR; Akash S; Mim M; Noor Alam M; Nepovimova E; Valis M; Kuca K; Sharma R Front Cell Dev Biol; 2022; 10():989471. PubMed ID: 36120565 [TBL] [Abstract][Full Text] [Related]
18. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure. Khan AU; Khan M; Cho MH; Khan MM Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755 [TBL] [Abstract][Full Text] [Related]